Finally, IL-1β has also been implicated in mediating toxicity of familial PD genes including LRRK2 [83], PINK1 [84,85] and Parkin [86] and it would be of interest to determine the effect of IL-1β inhibition in these genetic models to determine if this can ameliorate PD pathology. Here, LRRK2 is linked to Parkinson disease.